Work of the European Haemovigilance Network (EHN)

Transfusion Clinique et Biologique

Volumn 11, Issue 1, 2004, Pages 2-10

  Faber, Jean Claude ^a  

^a Luxembourg Red Cross   (Luxembourg)

Author keywords

Blood safety; European Haemovigilance Network; Haemovigilance; Surveillance of blood transfusion

Indexed keywords

AUSTRIA; BELGIUM; BLOOD COMPONENT THERAPY; DATA ANALYSIS; DENMARK; EDUCATIONAL TECHNOLOGY; EUROPE; EUROPEAN UNION; FINLAND; FRANCE; GERMANY; GREECE; HEALTH SURVEY; HUMAN; IMMUNOREACTIVITY; INCIDENCE; INTERNET; IRELAND; ITALY; LUXEMBOURG; NETHERLANDS; OUTCOMES RESEARCH; PORTUGAL; PROCESS DEVELOPMENT; PUBLIC HEALTH SERVICE; REVIEW; SPAIN; STANDARDIZATION; SWEDEN; UNITED KINGDOM; VALIDATION PROCESS;

EID: 1242316140     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2003.11.001     Document Type: Article

References (22)

1. Directive of the European Parliament and of the Council setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC; OJ 08.02.2003.
2. Faber J.C. Alert systems in haemovigilance, materiovigilance and reactovigilance: 42-45 4th EHS (European Haemovigilance Seminar), Athens. [Abstract Book]:12-13 December 2001.
3. Guide to the preparation, use and quality assurance of blood components. 9th ed:January 2003;. Recommendation No. R(95)15.
4. Faber J.C. Haemovigilance: definition and overview of current haemovigilance systems. TATM. 5:(1):2003;237-245.
5. Faber J.C. L'hémovigilance en Europe. Transfus Clin Biol. 7:2000;5-8.
6. Engelfriet C.P., Reesink H.W. Haemovigilance systems. Vox Sang. 77:1999;110-120.
7. Faber J.C. Basic clinical and organisational requirements for an effective haemovigilance. ESTM (European School for Transfusion Medicine) Residential Course, Sofia, Bulgaria:2002.
8. Faber J.C. Haemovigilance around the world. Vox Sang. 83:(Suppl 1):2002;71-76.
9. Williamson L.M., Lowe S., Love E., et al. Serious Hazards of Transfusion Annual Report 1996/97. ISBN 0 9532 789 0 5:18 March 1998.
10. Williamson L.M., Lowe S., Love E., et al. Serious Hazards of Transfusion Annual Report 1997/98. ISBN 0 9532 789 1 3:9 March 1999.
11. Love E., Williamson L.M., Cohen H., et al. Serious Hazards of Transfusion Annual Report 1998/99. ISBN 0 9532 789 2 1:7 April 2000.
12. Love E., Soldan K., et al. Serious Hazards of Transfusion Annual Report 1999/2000. ISBN 0 9532 789 3 X:29 March 2001.
13. Serious Hazards of Transfusion Annual Report 2000-2001. 2002;Serious Hazards of Transfusion Office, Manchester Blood Centre, Manchester, UK.
14. Williamson L.M., Lowe S., Love E., Cohen H., Soldan K., McClelland D.B.L., et al. The serious hazards of transfusion (SHOT) initiative - analysis of the first two annual reports. Br Med J. 319:1999;16-19.
15. Etablissement Français du Sang (EFS): Rapport d'activité 2001. 21-24 Octobre 2002.
16. AFSSAPS, Agence Française de Sécurité Sanitaire des Produits de Santé: Rapport 2002 Hémovigilance. 2002.
17. Ireland: Annual Report. 2002.
18. Debeir J., Noel L., Aullen J.P., Frette C., Sari F., Vo Mai M., et al. The French haemovigilance system. Vox Sang. 77:1999;77-81.
19. Andreu G., Morel P., Forestier F., et al. Haemovigilance network in France: organisation and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion. 42:2002;1356-1364.
20. Faber J.C. Compilation of European data in haemovigilance. 5th EHS (European Haemovigilance Seminar), Amsterdam [Abstract Book]:6-7 February 2003.
21. Williamson L.M. Transfusion Hazard reporting: powerful data, but do we know how best to use it? Editorial. Transfusion. 42:2002;1249-1252.
22. Faber J.C. Haemovigilance Procedure in Transfusion Medicine, ISBT VIII European Congress, Plenary and State-of-the-Art Book. 2003;19-26.